In particular, upon miR-154-5p overexpression, the protective effect of telmisartan on AngII-induced cardiac hypertrophy and apoptosis was partially abolished (Figures 5(h) and 5(i)). The gene discussed is AGT; the disease is cardiac hypertrophy.